3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
49
Burkitt Lymphoma
27
Leukemia, Biphenotypic, Acute
15
Leukemia, Myeloid, Acute
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Leukemia
10
Myelodysplastic Syndromes
9
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma
6
Leukemia, Myeloid, Accelerated Phase
6
Blast Crisis
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Graft vs Host Disease
5
Osteosarcoma
4
Medulloblastoma
4
Down Syndrome
4
Urinary Bladder Neoplasms
3
Recurrence
3
Primary Myelofibrosis
3
Neoplasm Metastasis
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Juvenile
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Thrombocythemia, Essential
2
Rhabdoid Tumor
2
Polycythemia Vera
2
Interventions
Nivolumab
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
Cisplatin
4
pembrolizumab
3
cabozantinib
3
avelumab
3
Ipilimumab
3
Carboplatin
3
CTLA-4 Antigen
3
enfortumab vedotin
2
Immunoglobulin G
2
Disulfides
2
Biopsy
2
tremelimumab
1
trastuzumab deruxtecan
1
tocilizumab
1
tamibarotene
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Propranolol
1
Platinum
1
Leucovorin
1
Lenalidomide
1
Fluorouracil
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
Methotrexate
×
1 year
×
Clear all
No trials found.